Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad

由 Okita, Riki, Shimizu, Katsuhiko, Nojima, Yuji, Saisho, Shinsuke, Nakata, Masao
發表在 Thorac Cancer (2021)

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 World J Surg Oncol (2015)

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 Onco Targets Ther (2016)

Urinary levels of prostaglandin E(2) are positively correlated with intratumoral infiltration of Foxp3(+) regulatory T cells in non-small cell lung cancer

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 Oncol Lett (2017)

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 Cancer Manag Res (2017)

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 Ther Clin Risk Manag (2019)

Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer

由 Okita, Riki, Maeda, Ai, Shimizu, Katsuhiko, Nojima, Yuji, Saisho, Shinsuke, Nakata, Masao
發表在 Oncotarget (2019)

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma...

由 Shimizu, Katsuhiko, Maeda, Ai, Yukawa, Takuro, Nojima, Yuji, Saisho, Shinsuke, Okita, Riki, Nakata, Masao
發表在 World J Surg Oncol (2014)

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy

由 Shimizu, Katsuhiko, Yukawa, Takuro, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 World J Surg Oncol (2015)

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 Ther Clin Risk Manag (2015)

Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer

由 Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Nojima, Yuji, Nakata, Masao
發表在 Ann Nucl Med (2015)

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells

由 OKITA, RIKI, SHIMIZU, KATSUHIKO, NOJIMA, YUJI, YUKAWA, TAKURO, MAEDA, AI, SAISHO, SHINSUKE, NAKATA, MASAO
發表在 Oncol Rep (2015)

Deciduoid type malignant pleural mesothelioma: a case report

由 Okita, Riki, Nojima, Yuji, Saisho, Shinsuke, Shimizu, Katsuhiko, Shirai, Ryo, Kanomata, Naoki, Oka, Mikio, Nakata, Masao
發表在 AME Case Rep (2018)